Trumps order: Kräver lägre läkemedelspriser

USA:s hälsominister väntas inom 30 dagar sätta tydliga mål för lägre läkemedelspriser, med fokus på viktminskningsläkemedel. Det uppgav Vita huset under måndagen.

RegFile AB

Efficient use of blood plasma

Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...

Clean solutions - Handling viscose substances with precision

Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...

“Everyone is screaming for talent”

Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...

Ny framgång för AZ:s antikroppskonjugat

Astra Zenecas samarbete med Daiichi Sankyos fortsätter att leverera nya cancerläkemedel. Nu har bolagens andra gemensamt utvecklade antikroppsläkemedelskonjugat...

Standardisation in automation

B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...

Lonza

Medeon AB

Trump stoppar information från hälsomyndigheter

Donald Trump inleder sin andra mandatperiod med att instruera flera hälsomyndigheter att pausa all kommunikation till allmänheten. Dessutom införs flera restriktioner mot NIH.

Product demo with features, software and best-practices

Get interesting insights about ZEISS O-INSPECT duo in our demo recording.

Samuel Lagercrantz: ”Will the Swedish life science strategy be updated with precision?”

What will the Swedish government focus on in the life science strategy that is being updated? And what should be prioritized in the strategy? Life Science Swede...

AI speeds up measurement process

How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.

Branschkritik mot EU:s nya läkemedelsförslag – ”En försämring”

”Som helhet en försämring”. ”En förlorad möjlighet”. Så reagerar svenska och europeiska branschorganisationer på kompromissen om en ny läkemedelslagstiftning i EU.

Nya covidvarianten Nimbus – det här vet vi

En ny sars-cov-2-variant sprider sig snabbt över världen och har nu nått Sverige. Symtomen liknar de som tidigare varianter orsakar, men kan enligt vissa rappor...

Norwegian company wins bidding battle for Sensidose

The lengthy battle to acquire medical device company Sensidose is apparently over. Generic medicines company EQL Pharma is pulling out, selling its shares and l...

Reliably gripping and turning small parts

The extremely compact rotary gripper module EHMD is the ideal choice in many life science applications where small objects need to be gripped and turned in conf...

EMA review confirms a risk of new cancer after CAR-T

CAR-T cancer therapies can, in rare cases, induce secondary cancers. The European Medicines Agency (EMA) now recognises this and requires a warning label to be ...

Ingrid Lönnstedt: Demystification of the power of a scientific study

”You surely do realize that even the smallest changes in study assumptions may influence the estimated sample size needed. And how is it even possible to guess ...

Kompauto Nordic AB

Merck Life Science A/S

”Information security must become part of the Swedish life science strategy”

Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.

“A major energy boost for the entire cancer vaccine field”

The development of cancer vaccines has accelerated in recent years. Norwegian Ultimovacs is one of the companies attempting to develop a new type of treatment l...

Sanofi backar efter besvikelse i KOL-studie

Blandade resultat för KOL-behandlingen Itepekimab i två fas III-studier fick Sanofis och Regenerons aktier att backa ordentligt på fredagen.